Specialty Pharma Journal

taglinebanner468x60

Sun05192013

Last update 08:38:54 PM EST

Back Surveys
Medical Health Care Provider Hereditary Angioedema Educational Needs Assessment
1. How would you rate the need for overall clinical knowledge regarding Hereditary Angioedema (HAE)?*
Strongly needed
Needed
Not really needed
Not at all needed
2. How would you rate the need for information about currently available and emerging therapies for HAE?*
Strongly needed
Needed
Not really needed
Not at all needed
3. How would you rate the need for information regarding the differentiation of HAE therapies? *
Strongly needed
Needed
Not really needed
Not at all needed
4. How would you rate the need for treatment guidelines and/or treatment algorithms for HAE? *
Strongly needed
Needed
Not really needed
Not at all needed
5. How would you rate the need for strategies for improving adherence in HAE therapy?*
Strongly needed
Needed
Not really needed
Not at all needed
6. Are there any factors you believe could impact adherence in this category? *
7. How would you rate the need for information on reimbursement issues related to HAE therapies? *
Strongly needed
Needed
Not really needed
Not at all needed
8. Are some particular sub-populations particularly of concern? If so, please explain.*
9. Would you like educational programs that discuss improving clinical outcomes while reducing overall expenditures in the treatment of HAE?*
YesNo
10. Would you like education for HAE on pharmacoeconomics and outcomes research?*
YesNo
11. Would you like educational material on contracting strategies for HAE?*
YesNo
12. Would you like educational programs on HAE that can be disseminated to providers in your network?*
YesNo
13. Would you like educational information on pipeline therapies in HAE?*
YesNo
14. Would you like educational material on how to implement interventions to improve compliance and adherence to plan policies and formularies on HAE therapies? *
YesNo
15. What have been the biggest issues or challenges in achieving positive outcomes for HAE patients? (e.g. therapy response, therapy switching, dose escalation, cost-effectiveness, reimbursement, compliance/adherence, etc.)*
16. Does your plan/organization contract with or utilize case managers who work directly with an HAE population? *
YesNo
17. Are you a case manager managing HAE patients? *
YesNo
18. If you answered yes to question 16 or 17, please provide the goals of case management with HAE patients.*
19. Please provide any comments on specific education you feel is needed for improving treatment of HAE.*

©2012 SpecialtyPharmaJournal.com. All rights reserved.